| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/23/2007 | US7166693 Treating flea allergic dermatitis |
| 01/23/2007 | US7166692 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 01/23/2007 | US7166691 Saposin C and receptors as targets for treatment of benign and malignant disorders |
| 01/23/2007 | US7166640 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/23/2007 | US7166594 Streptogramin derivatives, their preparation and compositions containing them |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166580 Such as N-(toluene-4-sulfonyl)-(2S-indolin-2-carbonyl)-L-phenylalanine; integrins, cd antigens (VLA-4); antiinflammatory agents |
| 01/23/2007 | US7166579 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 01/23/2007 | US7166578 Orally administered peptides synergize statin activity |
| 01/23/2007 | US7166577 Albumin having enhanced antimicrobial activity |
| 01/23/2007 | US7166576 Methods for preserving organs and tissues |
| 01/23/2007 | US7166575 Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
| 01/23/2007 | US7166574 Have a hydrophobic linker region and a heparin-binding region, useful as soluble biologics or as surface coatings for medical devices |
| 01/23/2007 | US7166572 12-benzyloxy-23-((1S)-2-benzyloxy-1-hydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydrox6-((1R)-1-hydroxy-ethyl)-20-hydroxymethyl-16-16]hexaazacyclohenicosin-9-yl]-12-methyltetradecanamide; echinocandin class with a substituent at the ornithine-5, homotyrosine-4 and ortho position; fungal infections |
| 01/23/2007 | US7166571 Immobilization; antidiabetic agents |
| 01/23/2007 | US7166570 Treating varicose or veins by injecting a composition silk made of polyalkylene oxide-polyester block copolymer into the lumen of a vein; anchoring implantable medical devices into or onto biological tissue |
| 01/23/2007 | US7166569 Method for the prevention of transplant rejection |
| 01/23/2007 | US7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement |
| 01/23/2007 | US7166468 Using nucleic acid fragment; expression cassettes; cell libraries; open reading frames |
| 01/23/2007 | US7166461 Animal growth regulator |
| 01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
| 01/23/2007 | US7166446 Vector with nucleotide sequence that comprises a yeast-recognized transcription and translation initiation and termination region; coding amino acid sequence for hybrid precursor polypeptide linked to heterologous mammalian protein such as platelet derived growth factor; genetic engineering |
| 01/23/2007 | US7166428 62112, a novel human dehydrogenase and uses thereof |
| 01/23/2007 | US7166302 Complexing agents for compositions containing inclusion complexes |
| 01/23/2007 | US7166298 Genetic immunization with cationic lipids |
| 01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 01/23/2007 | US7166291 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/23/2007 | US7166289 Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| 01/23/2007 | US7166288 Can also be used to inhibit metastasis of any tumor cells released in the subject's blood circulation during a surgical resection of a tumor |
| 01/23/2007 | US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers |
| 01/23/2007 | US7166285 Anti-IL-12 antibodies and compositions |
| 01/23/2007 | US7166284 Completitive binding; immunoassay, immunotherapy |
| 01/23/2007 | US7166283 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 01/23/2007 | US7166281 Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings |
| 01/23/2007 | US7166280 Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease |
| 01/23/2007 | US7166279 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 01/23/2007 | US7166278 Using swine organs; controlling gene expression |
| 01/23/2007 | US7166277 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator |
| 01/23/2007 | CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof |
| 01/23/2007 | CA2245804C Recombinant ribonuclease proteins |
| 01/23/2007 | CA2216169C Use of compositions comprising stabilized biologically effective compounds |
| 01/23/2007 | CA2141106C Glycopeptide antibiotic derivatives |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/21/2007 | CA2553239A1 Method of treating steatorrhea in infants |
| 01/18/2007 | WO2007009019A2 Protein compositions for promoting wound healing and skin regeneration |
| 01/18/2007 | WO2007008894A2 Cyclosporin compositions |
| 01/18/2007 | WO2007008848A2 Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus |
| 01/18/2007 | WO2007008780A2 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 01/18/2007 | WO2007008778A2 Formulations for enhanced mucosal delivery of pyy |
| 01/18/2007 | WO2007008732A2 Compositions and methods for suppressing axonal growth inhibition |
| 01/18/2007 | WO2007008684A2 Ligands of melanocortin receptors |
| 01/18/2007 | WO2007008603A1 Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus |
| 01/18/2007 | WO2007008376A2 Use of one or more metal carriers to selectively kill mammalian cells |
| 01/18/2007 | WO2007008154A1 Method for evaluating the effects of smoke on bronchioles |
| 01/18/2007 | WO2007007985A2 Ligand of regulating immune response, and use thereof in treating an immune response-related disease |
| 01/18/2007 | WO2007007787A1 Non-human gene-disrupted animal having adam11 gene disruption |
| 01/18/2007 | WO2007007327A2 Il-32 modulators |
| 01/18/2007 | WO2007007116A1 Defensin proteins |
| 01/18/2007 | WO2007007098A2 Promotion of epithelial regeneration |
| 01/18/2007 | WO2007007060A2 N- or c- terminally modified small peptides |
| 01/18/2007 | WO2007006751A2 Use of bpi protein for the treatment of disorders of the metabolism and cardiovascular disorders |
| 01/18/2007 | WO2007006548A2 Antibacterial amide macrocycles vii |
| 01/18/2007 | WO2007006484A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/18/2007 | WO2007006320A1 Drinkable oral insulin liquid and capsules |
| 01/18/2007 | WO2007006221A1 Synergistic time-delaying agent for local anestheic |
| 01/18/2007 | WO2007006101A1 Surface proteins of pasteurella multocida |
| 01/18/2007 | WO2006130769A9 Methods for treatment of growth disorders |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006124820A3 Materials and methods for regulating blood flow |
| 01/18/2007 | WO2006123207A3 A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent |
| 01/18/2007 | WO2006122542A3 Non-viral vector system for transporting nucleic acid into the lungs |
| 01/18/2007 | WO2006118805A9 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 01/18/2007 | WO2006116181A3 Regulatory t cell mediator proteins and uses thereof |
| 01/18/2007 | WO2006105448A3 Proliferation of muc1 expressing cells |
| 01/18/2007 | WO2006103274A9 Age inhibitors |
| 01/18/2007 | WO2006094193A3 Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| 01/18/2007 | WO2006094082A3 Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 01/18/2007 | WO2006091965A3 Nod1 as an anti-tumor agent |
| 01/18/2007 | WO2006081510A3 Methods for treating renal cell carcinoma |
| 01/18/2007 | WO2006078816A3 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide |
| 01/18/2007 | WO2006072048A3 Compositions and methods for identifying modulators of hausp |
| 01/18/2007 | WO2006056464A3 Compound with affinity for the cytotoxic t lymphocyte-associated antigen (ctla-4) |
| 01/18/2007 | WO2006036804A3 Methods for the treatment and prevention of diseases of biological conduits |
| 01/18/2007 | WO2006031117A8 Lipoxygenase inhibitor peptides and their use |
| 01/18/2007 | WO2006029028A3 Improved apo e analogs and methods for their use |
| 01/18/2007 | WO2006028595A3 Muteins of fibroblast growth factor 21 |
| 01/18/2007 | WO2006026002A3 T cell receptors with enhanced sensitivity recognition of antigen |
| 01/18/2007 | WO2006020207A3 Compounds for control of appetite |
| 01/18/2007 | WO2006009801A3 Compositions and methods for treating central precocious puberty |
| 01/18/2007 | WO2005115446A3 Detection and use of prolylcarboxypeptidase |
| 01/18/2007 | WO2005111058A9 Intracellular delivery of osteoinductive proteins and peptides |
| 01/18/2007 | WO2005084307A3 Use of lipid conjugates in the treatment of disease |
| 01/18/2007 | WO2005069726A3 Hybrid and chimeric polypeptides that regulate activation of complement |
| 01/18/2007 | WO2005056771A3 In vitro uptake of spam 1 (ph-20) by mammalian sperm |
| 01/18/2007 | WO2004091383A3 Breast endothelial cell expression patterns |
| 01/18/2007 | WO2004084837A3 Methods and compositions for treating and preventing inflammatory conditions |
| 01/18/2007 | WO2004054510A3 Method for identifying modulators of human orexin-2 receptor |
| 01/18/2007 | WO2004016762A3 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 01/18/2007 | US20070016967 Novel IFNgamma-like polypeptides |